These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 20136625)
41. Development of topical nanoemulsions containing the isoflavone genistein. Silva AP; Nunes BR; De Oliveira MC; Koester LS; Mayorga P; Bassani VL; Teixeira HF Pharmazie; 2009 Jan; 64(1):32-5. PubMed ID: 19216228 [TBL] [Abstract][Full Text] [Related]
42. Potential of nanoemulsions for intravenous delivery of rifampicin. Ahmed M; Ramadan W; Rambhu D; Shakeel F Pharmazie; 2008 Nov; 63(11):806-11. PubMed ID: 19069240 [TBL] [Abstract][Full Text] [Related]
43. Curcumin nanoemulsion for transdermal application: formulation and evaluation. Rachmawati H; Budiputra DK; Mauludin R Drug Dev Ind Pharm; 2015 Apr; 41(4):560-6. PubMed ID: 24502271 [TBL] [Abstract][Full Text] [Related]
44. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. Bhatia A; Kumar R; Katare OP J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383 [TBL] [Abstract][Full Text] [Related]
45. An investigation into the characteristics and drug release properties of multiple W/O/W emulsion systems containing low concentration of lipophilic polymeric emulsifier. Vasiljevic D; Parojcic J; Primorac M; Vuleta G Int J Pharm; 2006 Feb; 309(1-2):171-7. PubMed ID: 16406403 [TBL] [Abstract][Full Text] [Related]
46. Development and characterization of two nano-structured systems for topical application of flavanones isolated from Eysenhardtia platycarpa. Domínguez-Villegas V; Clares-Naveros B; García-López ML; Calpena-Campmany AC; Bustos-Zagal P; Garduño-Ramírez ML Colloids Surf B Biointerfaces; 2014 Apr; 116():183-92. PubMed ID: 24463153 [TBL] [Abstract][Full Text] [Related]
47. Hydrogel-thickened nanoemulsion system for topical delivery of lipophilic drugs. Mou D; Chen H; Du D; Mao C; Wan J; Xu H; Yang X Int J Pharm; 2008 Apr; 353(1-2):270-6. PubMed ID: 18215479 [TBL] [Abstract][Full Text] [Related]
48. In vitro permeation studies of nanoemulsions containing ketoprofen as a model drug. Kim BS; Won M; Lee KM; Kim CS Drug Deliv; 2008 Sep; 15(7):465-9. PubMed ID: 18712624 [TBL] [Abstract][Full Text] [Related]
49. Does lactobionic acid affect the colloidal structure and skin moisturizing potential of the alkyl polyglucoside-based emulsion systems? Tasic-Kostov MZ; Reichl S; Lukic MZ; Jaksic IN; Savic SD Pharmazie; 2011 Nov; 66(11):862-70. PubMed ID: 22204132 [TBL] [Abstract][Full Text] [Related]
50. An alkylpolyglucoside surfactant as a prospective pharmaceutical excipient for topical formulations: the influence of oil polarity on the colloidal structure and hydrocortisone in vitro/in vivo permeation. Savić S; Savić M; Tamburić S; Vuleta G; Vesić S; Müller-Goymann CC Eur J Pharm Sci; 2007 Apr; 30(5):441-50. PubMed ID: 17331708 [TBL] [Abstract][Full Text] [Related]
51. Pickering w/o emulsions: drug release and topical delivery. Frelichowska J; Bolzinger MA; Valour JP; Mouaziz H; Pelletier J; Chevalier Y Int J Pharm; 2009 Feb; 368(1-2):7-15. PubMed ID: 18992799 [TBL] [Abstract][Full Text] [Related]
52. Topical delivery of celecoxib using microemulsion. Subramanian N; Ghosal SK; Moulik SP Acta Pol Pharm; 2004; 61(5):335-41. PubMed ID: 15747689 [TBL] [Abstract][Full Text] [Related]
53. 3-Acetyl-11-keto-beta-boswellic acid loaded-polymeric nanomicelles for topical anti-inflammatory and anti-arthritic activity. Goel A; Ahmad FJ; Singh RM; Singh GN J Pharm Pharmacol; 2010 Feb; 62(2):273-8. PubMed ID: 20487208 [TBL] [Abstract][Full Text] [Related]
54. Vehicle effects on in vitro skin permeation of thiocolchicoside. Bonina F; Puglia C; Trombetta D; Dragani MC; Gentile MM; Clavenna G Pharmazie; 2002 Nov; 57(11):750-2. PubMed ID: 12611278 [TBL] [Abstract][Full Text] [Related]
56. Effect and mechanism of penetration enhancement of organic base and alcohol on glycyrrhetinic acid in vitro. Hao J; Sun Y; Wang Q; Tong X; Zhang H; Zhang Q Int J Pharm; 2010 Oct; 399(1-2):102-8. PubMed ID: 20713139 [TBL] [Abstract][Full Text] [Related]
57. Development and characterization of oleic acid vesicles for the topical delivery of fluconazole. Zakir F; Vaidya B; Goyal AK; Malik B; Vyas SP Drug Deliv; 2010 May; 17(4):238-48. PubMed ID: 20235758 [TBL] [Abstract][Full Text] [Related]
58. Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers. Alves MP; Scarrone AL; Santos M; Pohlmann AR; Guterres SS Int J Pharm; 2007 Aug; 341(1-2):215-20. PubMed ID: 17482392 [TBL] [Abstract][Full Text] [Related]
59. Semisolid formulations containing dimethyl sulfoxide and alpha-tocopherol for the treatment of extravasation of antiblastic agents. Casiraghi A; Ardovino P; Minghetti P; Botta C; Gattini A; Montanari L Arch Dermatol Res; 2007 Jul; 299(4):201-7. PubMed ID: 17370081 [TBL] [Abstract][Full Text] [Related]
60. Development and bioavailability assessment of ramipril nanoemulsion formulation. Shafiq S; Shakeel F; Talegaonkar S; Ahmad FJ; Khar RK; Ali M Eur J Pharm Biopharm; 2007 May; 66(2):227-43. PubMed ID: 17127045 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]